Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
Toxicologic Pathology
This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Capen, C. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Capen, C. C.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Mechanisms of Hormone-Mediated Carcinogenesis of the Ovary

Charles C. Capen

Department of Veterinary Biosciences, The Ohio State University, Columbus, Ohio 43210, USA, capen.2{at}osu.edu

Experimental ovarian carcinogenesis has been investigated in inbred and hybrid strains of mice and induced by a diversity of mechanisms including X-irradiation, oocytotoxic xenobiotic chemicals, ovarian grafting to ectopic or orthotopic sites, neonatal thymectomy, mutant genes reducing germ cell populations, and aging. Disruptions in the function of graafian follicles by a variety of mechanisms results in a spectrum of ovarian proliferative lesions, including tumors. The findings in mutant and genetically engineered mice support the concept of a secondary (hormonally mediated) mechanism of ovarian tumorigenesis in mice associated with sterility. Multiple pathogenic factors that either destroy or diminish the numbers of graafian follicles in the ovary result in decreased sex hormone secretion, especially estradiol-17 β, leading to a compensatory overproduction of pituitary gonadotrophins, particularly LH, which places the mouse ovary at an increased risk for developing tumors in chronic studies. The intense proliferation of ovarian surface epithelium and stromal (interstitial) cells with the development of unique tubular adenomas in response to sterility does not appear to have a counterpart in the ovaries of adult human females.

Key Words: Ovarian carcinogenesis • secondary mechanisms • selective estrogen receptor modulators • ovarian tumors in mice • pituitary luteinizing hormone overproduction • oocytotoxic xenobiotic chemicals • mutant mouse strains • estrogen receptor knockout mice.

References

  • Allison, R.H., and Morgan, K.T. (1987). Ovarian neoplasms in F344 rats and B6C3F1 mice. Environ Health Perspect 73, 91—106.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Biskind, M.S., and Biskind, J.R. (1944). Development of tumors in the rat ovary after transplantation into the spleen. Proc Soc Exp Biol Med 55, 176—9.[CrossRef]
  • Capen, C.C. (2001). Toxic responses of the endocrine system. In Cassarett and Doull's Toxicology: The Basic Science of Poisons (C. D. Klaassen, editor), 6th ed., pp. 711—59. McGraw Hill, New York.
  • Cattanach, B.M., Iddon, A., Charlton, H.M., Chiappa, S.A., and Fink, G. (1977). Gonadotropin releasing hormone deficiency in a mutant mouse with hypogonadism. Nature 269, 238—40.[CrossRef]
  • Cohen, I.R., Sims, M.L., Robbins, M.R., Laksmanan, M.C., Francis, P.C., and Long, G.G. (2000). The reversible effects of raloxifene on luteinizing hormone levels and ovarian morphology in mice. Reprod Toxicol 14, 37— 44.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Cook, L.S., Weiss, N.S., Schwartz, S.M., White, E., McKnight, B., Moore, D.E., and Daling, J.R. (1995). Population-based study of tamoxifen therapy and subsequent ovarian, endometrial, and breast cancers. JNatl Cancer Inst 87, 1359—64.[Abstract/Free Full Text]
  • Fisher, B., Costantino, J.P., Redmond, C.K., Redmond, C.K., Kavanah, M., Cronin, W.M., Vogel, V., Robidoux, A., Dimitrov, N., Atkins, J., Daly, M., Wieand, S., Tan-Chiu, E., Ford, L., and Wolmark, N. (1994). Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-J4. J Natl Cancer Inst 86, 527—37.[Abstract/Free Full Text]
  • Frith, C.H., Zuna, R.F., and Morgan, K. (1981). A morphologic classification and incidence of spontaneous ovarian neoplasms in three strains of mice. J Natl Cancer Inst 67, 693—702.[Web of Science][Medline] [Order article via Infotrieve]
  • Gardner, W.U. (1950). Ovarian and lymphoid tumors in female mice subsequent to Roentgen-ray irradiation and hormone treatment. Proc Soc Exp Biol Med 75, 434—6.[CrossRef][Medline] [Order article via Infotrieve]
  • Guthrie, M.J. (1957). Tumorigenesis in intrasplenic ovaries in mice. Cancer 10, 190—203.[Medline] [Order article via Infotrieve]
  • Hummel, K. (1954). Induced ovarian tumors. J Natl Cancer Inst 15, 711—5.[Web of Science][Medline] [Order article via Infotrieve]
  • Korach, K.S. (1994). Insights from the study of animals lacking functional estrogen receptor. Science 266, 1524—7.[Abstract/Free Full Text]
  • Li, M.H., and Gardner, W.U. (1949). Further studies on the pathogenesis of ovarian tumors in mice. Cancer Res 9, 35—44.[Abstract/Free Full Text]
  • Long, G.G., Cohen, I.R., Gries, C.L., Young, J.K., Francis, P.C., and Capen, C.C. (2001). Proliferative lesions of ovarian granulosa cell and reversible hormonal changaes induced in rats by a selective estrogen-receptor modulator. Toxicol Pathol 29, 403—10.[Abstract/Free Full Text]
  • Lubahan, D.B., Moyer, J.S., Golding, T.S., Couse, J.F., Korach, K.S., and Smithies, O. (1993). Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene. Proc Natl Acad Sci USA 90, 11162—6.[Abstract/Free Full Text]
  • Marchant, J. (1957). The chemical induction of ovarian tumours in mice. Br J Cancer 11, 452—64.[Web of Science][Medline] [Order article via Infotrieve]
  • Matzuk, M.M., Finegold, M.J., Su, J.G., Hsueh, A.J., and Bradley, A. (1992). {alpha}-inhibin is a tumour-suppressor gene with gonadal specificity in mice. Nature 360, 313—9.[CrossRef][Medline] [Order article via Infotrieve]
  • Murphy, E.D. (1972). Hyperplastic and early neoplastic changes in the ovaries of mice after genic deletion of germ cells. J Natl Cancer Inst 48, 1283—95.[Web of Science][Medline] [Order article via Infotrieve]
  • Murphy, E.D., and Beamer, W.G. (1973). Plasma gonadotropin levels during early stages of ovarian tumorigenesis in mice of the Wx/Wv genotype. Cancer Res 33, 721—3.[Abstract/Free Full Text]
  • Nishizuki, Y., Sakahura, T., and Taguchi, O. (1979). Mechanism of ovarian tumorigenesis in mice after neonatal thymectomy. JNatl CancerInstMonogr 51, 89—96.
  • Rehm, S., Dierksen, D., and Deerberg, F. (1984). Spontaneous ovarian tumors in Han:NMRI mice: histologic classification, incidence, and influence of food restriction. J Natl Cancer Inst 72, 1383—96.[Web of Science][Medline] [Order article via Infotrieve]
  • Risma, K.A., Clay, C.M., Nett, T.M., Wagner, T., Yun, J., and Nilson, J.H. (1995). Targeted overexpression of luteinizing hormone in transgenic mice leads to infertility, polycystic ovaries, and ovarian tumors. Proc Natl Acad Sci USA 92, 1322—6.[Abstract/Free Full Text]
  • Risma, K.A., Hirshfield, A.N., and Nilson, J.H. (1997). Elevated luteinizing hormone in prepubertal transgenic mice causes hyperandrogenemia, precocious puberty, and substantial ovarian pathology. Endocrinology 138, 3540—7.[Abstract/Free Full Text]
  • Taguchi, O., Michael, S.D., and Nishizuka, Y. (1988). Rapid induction of ovarian granulosa cell tumors by 7,12-dimethylbenzl(a)anthracene in neonatally estrogenized mice. Cancer Res 48, 425—9.[Abstract/Free Full Text]
  • Tennent, B.J., and Beamer, W.G. (1986). Ovarian tumors not induced by irradiation and gonadotropins in hypogonadal (hpg) mice. Biol Reprod 34, 751—60.[Abstract]
  • Witte, O.N. (1990). Steel local defines new multipotent growth factor. Cell 63, 5—6.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Yang, N.N., Venugopalan, M., Nardikar, S., and Glasevrook, A. (1996). Identification of an estrogen response element activated by metabolites of 17βestradiol and raloxifene. Science 273, 1222—5.[Abstract]

Toxicologic Pathology, Vol. 32, No. 2 suppl, 1-5 (2004)
DOI: 10.1080/01926230490462075


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?



This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Capen, C. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Capen, C. C.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?